SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD — Florence Nightingale Synthetic CCD

PatientFlorence Nightingale
Date of birth1988-05-12
IdentifiersMRN HR-NI004-SYN; SSN (made up) 000-04-9271
Document date2026-11-01
AuthorIsobel Marchetti, MD
CustodianSt. Posthumous Health Center

Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.

Reason for Visit

New patient visit for nearly three years of exhausting fatigue that worsens after exertion. Concerns: Nearly three years of exhausting fatigue since a severe febrile illness on an overseas deployment, with crashes lasting days after any push of work; Lightheaded with a racing heart when standing in a line or at the stove; Wants above all to keep doing her statistical and policy work, even if much of it has to be done from her sofa or bed. [S]

Allergies and Intolerances

AllergyReactionStatusEvidence
No known allergyactiveS

Medications

MedicationFrequencyRouteDatesStatusEvidence
Acetaminophen 500 mg oral tablet, one to two tablets by mouth every 6 hours as needed for muscle pain or headache, no more than 3 g a dayOne to two tablets by mouth every 6 hours as needed; no more than 3 g a dayOral route2025-11-03activeS
Cholecalciferol (vitamin D3) 50 mcg (2,000 units) oral tablet, one tablet by mouth dailyOne tablet by mouth dailyOral route2026-03-16activeS

Procedures

ProcedureDatesStatusEvidence
Ten-minute passive standing test (NASA lean test): heart rate 66/min supine and 92/min at 10 minutes (rise of 26/min); blood pressure 106/68 supine and 102/70 standing; lightheadedness and leg mottling from minute 6; no orthostatic hypotension and below the 30/min threshold for postural tachycardia syndrome2026-03-02 to 2026-03-02completedS
Repeat ten-minute passive standing test: heart rate 68/min supine and 86/min at 10 minutes (rise of 18/min); blood pressure 108/70 supine and 106/72 standing; mild lightheadedness only after minute 82026-09-14 to 2026-09-14completedS

Immunizations

DateVaccineStatusEvidence
2010-09-20Hepatitis B vaccine, adult three-dose series completedcompletedS
2021-09-13Tdap vaccinecompletedS
2025-10-20Influenza vaccine, 2025-2026 seasoncompletedS
2026-10-12Influenza vaccine, 2026-2027 seasoncompletedS

Past Medical History

Historical biography with true dates. These events are not part of the synthetic care timeline.

Historical dateHistoryEvidence
May 1855Crimean fever at Balaclava: dangerously ill and near death, then a slow and painful recovery; she called it typhusD (CLM-0003)
May 1855Retrospective interpretation of the Crimean fever as brucellosis, without laboratory confirmation (possible, not established)R (CLM-0004)
August 1857Overwork and failing health during the army health commission, with rest at Malvern, a collapse with cardiac symptoms, then nausea, insomnia, and palpitations; took to her bed or couch on doctors' orders but kept workingD (CLM-0006)

Family History

No family medical history is documented in the logged sources. Family history of real relatives is recorded only from documented or retrospective sources and is never synthesized.

Health Concerns

ConcernStatusEvidence
Nearly three years of exhausting fatigue since a severe febrile illness on an overseas deployment, with crashes lasting days after any push of workactiveS
Lightheaded with a racing heart when standing in a line or at the stoveactiveS
Wants above all to keep doing her statistical and policy work, even if much of it has to be done from her sofa or bedactiveS

Assessment

Most recent measures: Hemoglobin [Mass/volume] in Blood 12.9 on 2026-03-02; Leukocytes [#/volume] in Blood by Automated count 5.8 on 2026-03-02; Platelets [#/volume] in Blood by Automated count 246 on 2026-03-02; Sodium [Moles/volume] in Serum or Plasma 139 on 2026-03-02; Potassium [Moles/volume] in Serum or Plasma 4.2 on 2026-03-02; Creatinine [Mass/volume] in Serum or Plasma 0.72 on 2026-03-02; Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M 110 on 2026-03-02; Glucose [Mass/volume] in Serum or Plasma 86 on 2026-03-02; Calcium [Mass/volume] in Serum or Plasma 9.3 on 2026-03-02; Albumin [Mass/volume] in Serum or Plasma 4.3 on 2026-03-02; Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma 16 on 2026-03-02; Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma 19 on 2026-03-02; Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma 68 on 2026-03-02; Bilirubin.total [Mass/volume] in Serum or Plasma 0.6 on 2026-03-02; Phosphate [Mass/volume] in Serum or Plasma 3.6 on 2026-03-02; Erythrocyte [Sedimentation Rate] in Blood by Westergren method 8 on 2026-03-02; C reactive protein [Mass/volume] in Serum or Plasma 1.2 on 2026-03-02; Thyrotropin [Units/volume] in Serum or Plasma 1.9 on 2026-03-02; Hemoglobin A1c/Hemoglobin.total in Blood 5.1 on 2026-03-02; Ferritin [Mass/volume] in Serum or Plasma 48 on 2026-03-02; Tissue transglutaminase IgA Ab [Units/volume] in Serum 1 on 2026-03-02; Creatine kinase [Enzymatic activity/volume] in Serum or Plasma 92 on 2026-03-02; Cortisol [Mass/volume] in Serum or Plasma 14.2 on 2026-03-02; Cobalamin (Vitamin B12) [Mass/volume] in Serum or Plasma 410 on 2026-03-02; Folate [Mass/volume] in Serum or Plasma 12.4 on 2026-03-02; 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Mass/volume] in Serum or Plasma 34 on 2026-09-14; Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] 4 on 2026-10-12; Generalized anxiety disorder 7 item (GAD-7) total score [Reported.PHQ] 3 on 2026-10-12; PROMIS fatigue - version 1.0 Tscore 64 on 2026-09-14; PROMIS physical function - version 1.0 Tscore 38 on 2026-09-14; Pain severity - 0-10 verbal numeric rating [Score] - Reported 3 on 2026-09-14; Total score [AUDIT-C] 1 on 2026-10-12 [S]

Strengths and supports: Supports: a small team of trusted colleagues who visit her at home to work, and a wide network of correspondents [S]

Problems

ProblemClinical statusVerificationCodeProvenance
Myalgic encephalomyelitis/chronic fatigue syndrome, post-infectious, moderate severity, with orthostatic intolerance; synthetic modern diagnosis by NICE and IOM criteria, linked to her documented Crimean fever and decades of illness, which are only retrospectively and disputedly read as ME/CFSactiveconfirmed G93.32S — Synthetic diagnosis made by clinical criteria after exclusion tests in the modern episode; the historical reading of her illness as ME/CFS remains R and disputed.
Personal history of brucellosis diagnosed by serology during an overseas field-hospital deployment and treated with six weeks of doxycycline and rifampin; no evidence of relapseactiveconfirmed Z86.19S — Synthetic history echoing the disputed retrospective interpretation of her Crimean fever as brucellosis; not a historical diagnosis.
Vitamin D deficiencyactiveconfirmed E55.9S — Synthetic finding on the intake tests, reviewed at the two-week visit.
Acute viral upper respiratory infection with a short ME/CFS flare, resolved without antibioticsresolvedconfirmed J06.9S — Synthetic intercurrent illness at an unscheduled visit; it does not echo a documented illness.

Results

DateMeasureValueUnitReference rangeFlagProvenance
2026-03-02Hemoglobin [Mass/volume] in Blood12.9g/dL11.6-15 g/dLNormalS
2026-03-02Leukocytes [#/volume] in Blood by Automated count5.810*3/uL3.4-10.8 10*3/uLNormalS
2026-03-02Platelets [#/volume] in Blood by Automated count24610*3/uL150-450 10*3/uLNormalS
2026-03-02Sodium [Moles/volume] in Serum or Plasma139mmol/L135-145 mmol/LNormalS
2026-03-02Potassium [Moles/volume] in Serum or Plasma4.2mmol/L3.5-5.1 mmol/LNormalS
2026-03-02Creatinine [Mass/volume] in Serum or Plasma0.72mg/dL0.59-1.04 mg/dLNormalS
2026-03-02Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M110mL/min/{1.73_m2}>=60 mL/min/1.73 m²NormalS
2026-03-02Glucose [Mass/volume] in Serum or Plasma86mg/dL70-99 mg/dLNormalS
2026-03-02Calcium [Mass/volume] in Serum or Plasma9.3mg/dL8.6-10.2 mg/dLNormalS
2026-03-02Albumin [Mass/volume] in Serum or Plasma4.3g/dL3.5-5.2 g/dLNormalS
2026-03-02Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma16U/L7-35 U/LNormalS
2026-03-02Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma19U/L10-35 U/LNormalS
2026-03-02Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma68U/L44-121 U/LNormalS
2026-03-02Bilirubin.total [Mass/volume] in Serum or Plasma0.6mg/dL0.1-1.2 mg/dLNormalS
2026-03-02Phosphate [Mass/volume] in Serum or Plasma3.6mg/dL2.5-4.5 mg/dLNormalS
2026-03-02Erythrocyte [Sedimentation Rate] in Blood by Westergren method8mm/h<=20 mm/hNormalS
2026-03-02C reactive protein [Mass/volume] in Serum or Plasma1.2mg/L<=5 mg/LNormalS
2026-03-02Thyrotropin [Units/volume] in Serum or Plasma1.9m[IU]/L0.45-4.5 mIU/LNormalS
2026-03-02Hemoglobin A1c/Hemoglobin.total in Blood5.1%<=5.6%NormalS
2026-03-02Ferritin [Mass/volume] in Serum or Plasma48ng/mL30-150 ng/mLNormalS
2026-03-02Tissue transglutaminase IgA Ab [Units/volume] in Serum1U/mL<=3.9 U/mLNormalS
2026-03-02Creatine kinase [Enzymatic activity/volume] in Serum or Plasma92U/L26-192 U/LNormalS
2026-03-02Cortisol [Mass/volume] in Serum or Plasma14.2ug/dL6.2-19.4 ug/dLNormalS
2026-03-02Cobalamin (Vitamin B12) [Mass/volume] in Serum or Plasma410pg/mL232-1245 pg/mLNormalS
2026-03-02Folate [Mass/volume] in Serum or Plasma12.4ng/mL>=5.9 ng/mLNormalS
2026-03-0225-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Mass/volume] in Serum or Plasma17ng/mL30-100 ng/mLLowS
2026-03-02Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]8{score}S
2026-03-02Generalized anxiety disorder 7 item (GAD-7) total score [Reported.PHQ]5{score}S
2026-03-02PROMIS fatigue - version 1.0 Tscore71{score}S
2026-03-02PROMIS physical function - version 1.0 Tscore32{score}S
2026-03-02Pain severity - 0-10 verbal numeric rating [Score] - Reported4{score}S
2026-06-01Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]6{score}S
2026-06-01PROMIS fatigue - version 1.0 Tscore67{score}S
2026-06-01PROMIS physical function - version 1.0 Tscore35{score}S
2026-06-01Pain severity - 0-10 verbal numeric rating [Score] - Reported3{score}S
2026-09-1425-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Mass/volume] in Serum or Plasma34ng/mL30-100 ng/mLNormalS
2026-09-14Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]5{score}S
2026-09-14Generalized anxiety disorder 7 item (GAD-7) total score [Reported.PHQ]4{score}S
2026-09-14PROMIS fatigue - version 1.0 Tscore64{score}S
2026-09-14PROMIS physical function - version 1.0 Tscore38{score}S
2026-09-14Pain severity - 0-10 verbal numeric rating [Score] - Reported3{score}S
2026-10-12Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]4{score}S
2026-10-12Generalized anxiety disorder 7 item (GAD-7) total score [Reported.PHQ]3{score}S
2026-10-12Total score [AUDIT-C]1{score}S

Social History

Vital Signs

DateMeasureValueUnitProvenance
2026-03-02Body height170cmS
2026-03-02Body weight55kgS
2026-03-02Body mass index (BMI) [Ratio]19kg/m2S
2026-03-02Systolic blood pressure104mm[Hg]S
2026-03-02Diastolic blood pressure66mm[Hg]S
2026-03-02Heart rate78/minS
2026-03-02Respiratory rate14/minS
2026-03-02Body temperature36.6CelS
2026-03-02Oxygen saturation in Arterial blood by Pulse oximetry99%S
2026-03-16Body height170cmS
2026-03-16Body weight55.2kgS
2026-03-16Body mass index (BMI) [Ratio]19.1kg/m2S
2026-03-16Systolic blood pressure106mm[Hg]S
2026-03-16Diastolic blood pressure68mm[Hg]S
2026-03-16Heart rate76/minS
2026-03-16Respiratory rate14/minS
2026-03-16Body temperature36.5CelS
2026-03-16Oxygen saturation in Arterial blood by Pulse oximetry99%S
2026-06-01Body height170cmS
2026-06-01Body weight55.6kgS
2026-06-01Body mass index (BMI) [Ratio]19.2kg/m2S
2026-06-01Systolic blood pressure108mm[Hg]S
2026-06-01Diastolic blood pressure68mm[Hg]S
2026-06-01Heart rate74/minS
2026-06-01Respiratory rate14/minS
2026-06-01Body temperature36.6CelS
2026-06-01Oxygen saturation in Arterial blood by Pulse oximetry99%S
2026-09-14Body height170cmS
2026-09-14Body weight56kgS
2026-09-14Body mass index (BMI) [Ratio]19.4kg/m2S
2026-09-14Systolic blood pressure108mm[Hg]S
2026-09-14Diastolic blood pressure70mm[Hg]S
2026-09-14Heart rate72/minS
2026-09-14Respiratory rate14/minS
2026-09-14Body temperature36.6CelS
2026-09-14Oxygen saturation in Arterial blood by Pulse oximetry99%S
2026-07-20Body height170cmS
2026-07-20Body weight55.4kgS
2026-07-20Body mass index (BMI) [Ratio]19.2kg/m2S
2026-07-20Systolic blood pressure102mm[Hg]S
2026-07-20Diastolic blood pressure64mm[Hg]S
2026-07-20Heart rate92/minS
2026-07-20Respiratory rate16/minS
2026-07-20Body temperature37.6CelS
2026-07-20Oxygen saturation in Arterial blood by Pulse oximetry98%S
2026-10-12Body height170cmS
2026-10-12Body weight56.1kgS
2026-10-12Body mass index (BMI) [Ratio]19.4kg/m2S
2026-10-12Systolic blood pressure108mm[Hg]S
2026-10-12Diastolic blood pressure68mm[Hg]S
2026-10-12Heart rate72/minS
2026-10-12Respiratory rate14/minS
2026-10-12Body temperature36.6CelS
2026-10-12Oxygen saturation in Arterial blood by Pulse oximetry99%S

Encounters

DatePurposeStatusProvenance
2026-03-02New patient visit for nearly three years of exhausting fatigue that worsens after exertionfinishedS
2026-03-16Two-week review of exclusion tests, ME/CFS diagnosis and care plan, and infectious diseases consultationfinishedS
2026-06-01Three-month ME/CFS energy management reviewfinishedS
2026-09-14Six-month ME/CFS care plan reviewfinishedS
2026-07-20Same-day sick visit for a cold with an ME/CFS flarefinishedS
2026-10-12Adult preventive visitfinishedS

Plan of Treatment

InterventionStatusGuidelineProvenance
Diagnose ME/CFS by clinical criteria after exclusion tests, explain that it is a real illness with no diagnostic test, and give her a written care and support plan, including a flare plancompletedGL-NICE-MECFS-2021, GL-CDC-MECFSS
Energy management led by the patient: an activity and symptom diary, planned rest before and between tasks, work broken into short blocks, and heart-rate awareness; no graded exercise therapy or fixed increases in activitycompletedGL-NICE-MECFS-2021, GL-CDC-MECFS, GL-MAYO-MECFS-2023S
Infectious diseases consultation to look for relapsed or focal brucellosis or another persisting infection before attributing her symptoms to ME/CFScompletedGL-NICE-MECFS-2021, GL-CDC-BRUC, GL-BRUC-2005S
Orthostatic intolerance measures: 2 to 2.5 L of fluid a day, more salt with meals, waist-high compression garments, and tasks done seated or reclined; repeat the standing test at six monthscompletedGL-NICE-MECFS-2021, GL-MAYO-MECFS-2023S
Sleep, pain, and cognitive symptom care: a regular sleep window with rest periods kept short, acetaminophen as needed, no sedatives or opioids, and memory aids for workcompletedGL-NICE-MECFS-2021, GL-CDC-MECFSS
Vitamin D repletion with cholecalciferol 2,000 units daily, rechecked after about three monthscompletedGL-NICE-MECFS-2021S
Review the care plan at every visit, with PHQ-9, PROMIS fatigue and physical function scores, and a pain score; primary care review at least yearly and more often while the plan is newcompletedGL-NICE-MECFS-2021S
Workplace adjustments: home working, a reclined workstation, flexible hours, and meetings by video or at her homecompletedGL-NICE-MECFS-2021, GL-CDC-MECFSS

Goals

GoalTargetStatusOutcomeProvenance
Agree an energy management plan with a stable baseline and no more than one crash a month by the six-month review2026-09-14completedOne flare in three months, after a cold; no crash from overexertion since the summerS
Keep working within her energy limits, aiming for four hours a day in planned blocks by the six-month review2026-09-14completedWorking four to five hours a day in 45-minute blocks with rest betweenS
Fewer orthostatic symptoms with fluids, salt, compression, and seated or reclined tasks by the three-month review2026-06-01completedLightheaded on standing two or three times a week instead of dailyS
Replete vitamin D to 30 ng/mL or higher2026-09-14completed25-hydroxyvitamin D 34 ng/mLS

Functional Status

Mental Status